[1]
« Not All Bruton’s Tyrosine Kinase Inhibitors are Created Equal: Pharmacologic Insights into the Efficacy, Resistance, and Safety of Covalent and Non-covalent BTK Inhibitors », Can Hematol Today, vol. 5, nᵒ s02, p. 2–7, mai 2026, doi: 10.58931/cht.2026.5s0282.